Preclinical and clinical pharmacology of EPI-7386, an androgen receptor N-terminal domain inhibitor for castration-resistant prostate cancer.

Le Moigne, R; Pearson, P; Lauriault, V; Hong, NH; Virsik, P; Zhou, HJ; Cesano, A

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (6):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索